# Vaccinex Inc. (VCNX)

Source: https://www.quantisnow.com/company/VCNX
Generated: 2026-11-10T12:11:20.385Z

- Ticker: VCNX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- SEC CIK: 0001205922
- Website: vaccinex.com

## About

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody that is in Phase 1 and 2 clinical trials for the treatment of non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), Huntington's disease, Alzheimer's disease, osteosarcoma, and melanoma. The company is also developing VX5, a human antibody to CXCL13 that is in preclinical development for the treatment of MS and for other autoimmune disorders; and VX25, a bi-specific molecule based on natural killer T (NKT) vaccine platform for the therapeutic application of NKT cell stimulation for cancer immunotherapy. Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York.

## Latest VCNX news and filings

- 2026-10-07 12:30 UTC [SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study](https://www.quantisnow.com/insight/sema4d-blockade-reshapes-the-tumor-immune-environment-in-neoadjuvant-melanoma-6739814)
- 2026-07-08 12:30 UTC [Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026](https://www.quantisnow.com/insight/vaccinex-to-report-new-biomarker-data-and-plans-for-phase-6630985)
- 2026-04-30 00:05 UTC [Vaccinex Reports 2025 Annual Financial Results](https://www.quantisnow.com/insight/vaccinex-reports-2025-annual-financial-results-6522184)
- 2025-12-23 13:01 UTC [Vaccinex, Inc. Announces $60 million Agreement to Finance a Phase 2b clinical trial of pepinemab to treat Alzheimer's Disease](https://www.quantisnow.com/insight/vaccinex-inc-announces-60-million-agreement-to-finance-a-phase-6326241)
- 2025-05-27 12:45 UTC [Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting](https://www.quantisnow.com/insight/vaccinex-to-report-promising-new-clinical-results-of-neoadjuvant-treatment-6058313)
- 2025-04-21 12:45 UTC [Vaccinex to Report Promising New Clinical Data Revealing Pepinemab's Unique Mechanism to Enhance Immunotherapy at Annual Meeting of American Association for Cancer Research (AACR)](https://www.quantisnow.com/insight/vaccinex-to-report-promising-new-clinical-data-revealing-pepinemabs-unique-5994256)
- 2025-04-15 21:12 UTC [SEC Form 10-K] [SEC Form 10-K filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-vaccinex-inc-5988937)
- 2025-04-01 11:01 UTC [SEC Form NT 10-K filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-vaccinex-inc-5968437)
- 2025-03-27 12:24 UTC [SEC Form 15-12G filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-vaccinex-inc-5962366)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960207)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960205)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960204)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960202)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960200)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960198)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960193)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960191)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960190)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960187)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960184)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960182)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960179)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960173)
- 2025-03-26 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vaccinex-inc-5960170)
- 2025-03-25 12:51 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958890)
- 2025-03-25 12:50 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958888)
- 2025-03-25 12:48 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958886)
- 2025-03-25 12:46 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958885)
- 2025-03-25 12:45 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958879)
- 2025-03-25 12:43 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958874)
- 2025-03-25 12:41 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958872)
- 2025-03-25 12:40 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958869)
- 2025-03-25 12:38 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958866)
- 2025-03-25 12:36 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958864)
- 2025-03-25 12:35 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958862)
- 2025-03-25 12:34 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958860)
- 2025-03-25 12:31 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958853)
- 2025-03-25 12:30 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958844)
- 2025-03-25 12:28 UTC [SEC Form POS AM filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vaccinex-inc-5958802)
- 2025-03-25 12:26 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vaccinex Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vaccinex-inc-5958795)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VCNX
- Earnings history: https://www.quantisnow.com/earnings/VCNX
- Dividend history: https://www.quantisnow.com/dividends/VCNX
- Insider transactions: https://www.quantisnow.com/insiders/VCNX
- Options chain: https://www.quantisnow.com/options/VCNX
- SEC 8-K filings only: https://www.quantisnow.com/company/VCNX/8-k
- RSS and alerts for VCNX: https://www.quantisnow.com/docs/rss-feeds.md